Literature DB >> 11503519

Chemical construction of immunotoxins.

V Ghetie1, E S Vitetta.   

Abstract

Immunotoxins are chimeric proteins consisting of an antibody linked to a toxin. The antibodies most frequently used for the preparation of immunotoxins are murine monoclonal antibodies belonging to IgG isotype. The most used toxins for the chemical construction of immunotoxins are Ricin toxin A chain in its deglycosylated form and recombinant Pseudomonas endotoxin with the cell-binding domain deleted. The linkage of the antibody to the toxin can be accomplished by chemical methods using reagents that crosslink antibody to toxin. The usual crosslinkers attach disulfide groups into the antibody molecule to form a disulfide bond between the antibody and the toxin. Disulfide bonds are susceptible to reduction in the cytoplasm of the targeted cells thereby releasing the toxin so that it can exert its cytotoxic activity only into the cells (e.g., tumor cells) binding the antibody moiety. This article describes various methods to obtain antibodies and toxins and several procedures for their crosslinking as well as "in vitro" and "in vivo" testing of the immunotoxins efficacy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11503519     DOI: 10.1385/MB:18:3:251

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  41 in total

1.  Purification of ricin A1, A2, and B chains and characterization of their toxicity.

Authors:  R J Fulton; D C Blakey; P P Knowles; J W Uhr; P E Thorpe; E S Vitetta
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

Review 2.  Immunotoxins in the therapy of cancer: from bench to clinic.

Authors:  V Ghetie; E Vitetta
Journal:  Pharmacol Ther       Date:  1994-09       Impact factor: 12.310

3.  Preparation of F(ab')2 fragments from mouse IgG of various subclasses.

Authors:  E Lamoyi; A Nisonoff
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

4.  A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay.

Authors:  R J Duncan; P D Weston; R Wrigglesworth
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.

Authors:  P E Thorpe; D C Blakey; A N Brown; P P Knowles; R E Knyba; P M Wallace; G J Watson; E J Wawrzynczak
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

6.  More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through thiol groups in the hinge.

Authors:  S Hashida; M Imagawa; S Inoue; K H Ruan; E Ishikawa
Journal:  J Appl Biochem       Date:  1984 Feb-Apr

7.  Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol.

Authors:  M Ogata; V K Chaudhary; I Pastan; D J FitzGerald
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.486

8.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

Authors:  V S Allured; R J Collier; S F Carroll; D B McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 12.779

9.  Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

Authors:  J Hwang; D J Fitzgerald; S Adhya; I Pastan
Journal:  Cell       Date:  1987-01-16       Impact factor: 66.850

10.  Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice.

Authors:  R J Kreitman; H J Hansen; A L Jones; D J FitzGerald; D M Goldenberg; I Pastan
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 13.312

View more
  4 in total

1.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

Review 2.  Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.

Authors:  Franco Dosio; Paola Brusa; Luigi Cattel
Journal:  Toxins (Basel)       Date:  2011-07-14       Impact factor: 4.546

3.  Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861.

Authors:  Cheenu Bhargava; Horst Dürkop; Xiangli Zhao; Alexander Weng; Matthias F Melzig; Hendrik Fuchs
Journal:  Mol Oncol       Date:  2017-09-15       Impact factor: 6.603

4.  Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers.

Authors:  Dianoush Falahatgar; Safar Farajnia; Nosratollah Zarghami; Asghar Tanomand; Shiva Ahdi Khosroshahi; Bahman Akbari; Hadi Farajnia
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.